Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.

about

Gut microbiome modulates efficacy of immune checkpoint inhibitors.Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma

P2860

Q55240704-4A3200E6-C948-4D36-8052-5438509FE24B Q59132347-7DBB92C5-82EB-4416-8FBB-E7A5DC732AF5

P2860

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.

Item

http://www.wikidata.org/entity/Q47096567

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Serial pseudoprogression of me ...... with nivolumab: a case report.

@en

Serial pseudoprogression of me ...... with nivolumab: a case report.

@nl

type

Item

label

Serial pseudoprogression of me ...... with nivolumab: a case report.

@en

Serial pseudoprogression of me ...... with nivolumab: a case report.

@nl

prefLabel

Serial pseudoprogression of me ...... with nivolumab: a case report.

@en

Serial pseudoprogression of me ...... with nivolumab: a case report.

@nl

P1476

Serial pseudoprogression of me ...... with nivolumab: a case report.

@en

P2093

Chihiro Kondoh

http://www.w3.org/2001/XMLSchema#string

Harushi Udagawa

http://www.w3.org/2001/XMLSchema#string

Hiromichi Nakajima

http://www.w3.org/2001/XMLSchema#string

Jun Masuda

http://www.w3.org/2001/XMLSchema#string

Junichi Shindoh

http://www.w3.org/2001/XMLSchema#string

Keiichi Kinowaki

http://www.w3.org/2001/XMLSchema#string

Masaki Ueno

http://www.w3.org/2001/XMLSchema#string

Miyuki Uchiyama

http://www.w3.org/2001/XMLSchema#string

Ryosuke Oki

http://www.w3.org/2001/XMLSchema#string

Shigehisa Kitano

http://www.w3.org/2001/XMLSchema#string

P2860

Immune Checkpoint Blockade in Cancer Therapy

Cancer statistics, 2010

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

Nivolumab in previously untreated melanoma without BRAF mutation

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

P2888

s12885-017-3785-4

P304

778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S12885-017-3785-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yukinori Ozaki

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092808473

http://www.w3.org/2001/XMLSchema#string

P698

29162045

http://www.w3.org/2001/XMLSchema#string

P932

5696908

http://www.w3.org/2001/XMLSchema#string

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.

about

P2860

P2860

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932